SCHEMBL5152604

SCHEMBL5152604

O=C(O)c1ccc(CN2C(=O)CNC23CCN(C(=O)Cc2ccccc2)CC3)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
ALDH1A1 P00352 4/20 0.45
LMNA P02545 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
HPGD P15428 1/20 0.45
HTT P42858 1/20 0.45
CRBN Q96SW2 1/20 0.43
KDM4E B2RXH2 2/20 0.43
OPRD1 P41143 1/20 0.42
USP2 O75604 1/20 0.42
GAA P10253 1/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
ROCK2 O75116 1/20 0.41
ROCK1 Q13464 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
HSD11B1 P28845 1/20 0.41
GPR183 P32249 1/20 0.41
GFER P55789 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1801345 0.89 MEN1 (0.45) HDAC1HDAC6ALDH1A1LMNASMN1; SMN2
SCHEMBL24106950 0.80 OPRD1 (0.46) ALDH1A1LMNAHTTKDM4EOPRD1
SCHEMBL1801385 0.80 RIPK1 (0.52) ALDH1A1LMNAHPGDKDM4EMEN1
SCHEMBL5155027 0.80 L3MBTL1 (0.44) ALDH1A1SMN1; SMN2HPGDKDM4EMEN1
SCHEMBL5151635 0.79 KMT2A (0.42) ALDH1A1SMN1; SMN2HPGDKDM4EMEN1
SCHEMBL5151551 0.78 MEN1 (0.51) ALDH1A1SMN1; SMN2HPGDHTTKDM4E
SCHEMBL5155488 0.77 POLB (0.41) ALDH1A1LMNASMN1; SMN2MEN1KMT2A
SCHEMBL24106959 0.77 RIPK1 (0.39) ALDH1A1LMNAHTTCRBNKDM4E
SCHEMBL15423926 0.76 FAAH (0.56) ALDH1A1KDM4EOPRD1
SCHEMBL5174941 0.76 IP6K1 (0.38) OPRD1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070015784-A1 Subsitituted 1,4,8- triazaspiro [4,5]decan-2-one compounds GRUENENTHAL GMBH (DE) 2007-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070015784-A1 Subsitituted 1,4,8- triazaspiro [4,5]decan-2-one compounds SI, SSTR4, SLC10A2 HDAC1 376/4885HDAC6 222/4885ALDH1A1 2780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.